A PE firm is looking for an exit for a portfolio company - what are the considerations for doing an IPO vs. selling to another PE firm vs. selling to a strategic buyer, and how are these considerations impacted by market dynamics?
The PE firm weighs valuation potential, certainty of close, speed of liquidity, and execution costs across IPO, secondary buyout, and strategic sale, with market dynamics—equity valuations, credit conditions, and industry consolidation—shifting the optimal exit, often best navigated via a dual-track process.
Intuition
Each buyer type has a different source of value creation — public markets price growth expectations, strategics pay for synergies they can uniquely capture, and PE firms pay based on leverage and operational improvement they can still extract. Market conditions shift which buyer's value-creation thesis is most compelling and financeable at any given time, directly affecting which route maximizes the seller's proceeds and execution certainty.
Watch
A common trap is saying IPO always yields the highest valuation. In practice, a strategic buyer paying a 30%+ synergy premium can exceed IPO valuation, and when you factor in IPO discount (~10-15%), lockup illiquidity, and underwriting fees (5-7%), the net effective proceeds from an IPO can be meaningfully lower than a strategic sale. Interviewers may test whether you understand that headline IPO valuation ≠ realized proceeds.
Deep Dive
Determine the key trade-offs a PE firm faces when choosing between an IPO, a secondary (PE-to-PE) sale, and a strategic sale, and how market conditions shift the calculus.
Phase 1: Core Comparison Across Exit Routes
| Dimension | IPO | Secondary Buyout (PE-to-PE) | Strategic Sale |
|---|---|---|---|
| Valuation potential | Can offer the highest headline valuation in strong equity markets, especially for high-growth stories, but realized proceeds are reduced by partial sell-down, fees, and post-IPO market risk | Moderate — buyer underwrites to a target IRR (typically 20%+), so they back into price from projected exit value, limiting what they pay today | Often highest net proceeds when synergies are meaningful, because a strategic can pay above standalone value |
| Certainty of close | Lowest — subject to SEC process, roadshow reception, book-building; can be pulled | High — PE buyer is sophisticated, fast diligence, committed financing | High — but regulatory/antitrust risk can kill or delay |
| Speed of liquidity | Slow — lockup period (typically 90–180 days) means PE firm holds shares post-IPO; full exit may take 12–24 months via secondary offerings | Immediate — 100% cash at close (or close to it) | Immediate — 100% cash at close (sometimes with earnouts or rollover) |
| % of value realized at close | Partial — PE sells only a slice at IPO; remaining stake subject to stock price risk | ~100% | ~100% (minus any rollover or contingent consideration) |
| Execution cost | Highest — underwriting fees (3–7% of proceeds), legal, S-1 preparation, ongoing public company costs (SOX compliance, IR team) | Moderate — advisory fee, stapled financing cost | Moderate — advisory fee, potential break fees |
| Control of process | Low post-IPO — public shareholders, board governance, quarterly disclosure | Full control of negotiation and timeline | Full control of negotiation; buyer may impose conditions |
| Management consideration | Management often prefers IPO (prestige, option packages, independence) | New PE sponsor may replace or re-incentivize management | Strategic may integrate/eliminate management roles |
Phase 2: How the PE Firm Thinks About Returns
The PE firm maximizes and :
- IPO: Cash flows are staggered (partial sale at IPO, secondary sales over time) → may offer a high headline valuation, but IRR can be diluted by delayed liquidity and exposure to post-IPO stock performance
- Secondary buyout: Lump sum at close → often attractive for certainty and near-term IRR, especially if financing markets are supportive
- Strategic sale: Lump sum at close, often at the highest absolute price when synergy premium is large → can maximize both MOIC and IRR
Phase 3: Market Dynamics Impact
| Market Condition | Effect on IPO | Effect on Secondary Buyout | Effect on Strategic Sale |
|---|---|---|---|
| Bull equity markets / high public multiples | Strongly favors IPO — higher pricing, investor appetite for new issues | Neutral to positive — PE buyers can underwrite higher exit multiples | Positive — strategic boards more willing to pay up in confident markets |
| Tight credit / high interest rates | Negative — public multiples and IPO demand often weaken, though impact is less direct than for LBO buyers | Strongly negative — PE buyer relies on leverage; higher rates compress LBO bid price because more cash flow services debt, less supports purchase price | Mildly to moderately negative — strategics are less reliant on debt, but financing costs and board caution can still reduce appetite |
| Easy credit / cheap leverage | Mixed to positive — supportive risk appetite can help IPOs | Strongly positive — cheap debt means PE buyer can bid higher while still hitting return targets | Mildly positive |
| Depressed M&A activity / recession | IPO window likely closed — deals get pulled | PE 'dry powder' may sustain bids, but at lower multiples | Strategics may pause acquisitions to preserve cash |
| Hot IPO window (high first-day pops) | Very favorable — signals strong demand | Indirectly positive — PE buyer sees a credible public-market exit for their own hold | Neutral |
| Industry consolidation wave | IPO possible but strategic premium may exceed public-market valuation | PE buyers may struggle to compete with strategic synergy bids | Strongly favors strategic — competitive tension among multiple strategics drives price up |
| Regulatory tightening (antitrust) | Limited direct impact | Limited direct impact | Negative — strategic combinations more likely to face FTC/DOJ challenge, reducing certainty |
Phase 4: Decision Framework (Simplified)
- Run a dual-track process (prepare IPO filing + run a private sale process simultaneously) to maximize optionality and competitive tension
- Compare indicative valuations: strategic bids (with synergy premium) vs. PE bids (constrained by leverage and IRR targets) vs. IPO valuation range from underwriters
- Discount IPO proceeds for: lockup-period stock price risk, partial monetization, execution risk, and ongoing public company costs
- Adjust for certainty of close: assign probability weights to each path completing
- Select exit that maximizes risk-adjusted, time-weighted proceeds — i.e., the path with the highest expected present value of total cash received
Key linkage the interviewer wants to hear: Strategics can often pay the most when synergies are meaningful. A secondary PE buyer is constrained by return hurdles and leverage availability. An IPO can offer the highest headline valuation in the right market, but usually has the lowest certainty and slowest full liquidity. Dual-track processes exist because the optimal exit depends on real-time market conditions.